Monographie - Pentamidine isetionate

Ultimele actualizari :
08/05/2024

Pentamidine isetionate

Formula chimica

Denumirea comerciala

Trade names are indicative and excipients composition can be different depending on the country and manufacturers

DBL Pentamidine isetionate	Malaezia
Manicare	Argentina
Nebupent	SUA
Pentacarinat	Austria, Belgia, Columbia, Danemarca, Elvetia, Finlanda, Franta, Germania, Grecia, Italia, Luxemburg, Marea Britanie, Noua Zeelandă, Olanda, Spania, Suedia
Pentam	SUA
Pentamidina	Argentina, Spania
Pentamidine isethionate	Australia, Canada, Malaezia, SUA
Pentamina	Portugalia

Bibliografie : Pentamidine isetionate

	Tip	Publicare
36	Ziar	Alex S, Gupta SL, Minor JR, Turcovski-Corrales S, Gallelli JF, Taub D, Piscitelli SC. Compatibility and activity of aldesleukin (recombinant interleukin-2) in presence of selected drugs during simulated Y-site administration: Evaluation of three methods. Am J Health-Syst Pharm 1995 ; 52: 2423-2426.
73	Ziar	Lor E, Takagi J. Visual compatibility of foscarnet with other injectable drugs. Am J Hosp Pharm 1990 ; 47: 157-159.
198	Ziar	Gayed AA, Kheshary PR, Hinkle RL. Visual compatibility of diltiazem injection with various diluents and medications during simulated Y-site injection. Am J Health-Syst Pharm 1995 ; 52: 516-520.
275	Ziar	Lewis JD, El-Gendy A. Cephalosporin-pentamidine isethionate incompatibilities. Am J Health-Syst Pharm 1996 ; 53: 1461-1462.
337	Ziar	Bashaw ED, Amantea MA, Minor JR, Galleli JF. Visual compatibility of zidovudine with other drugs during simulated Y-site administration. Am J Hosp Pharm 1988 ; 45: 2532-2533.
424	Ziar	De NC, Alam AS, Kapoor JN. Stability of pentamidine isethionate in 5% dextrose and 0.9% sodium chloride injections. Am J Hosp Pharm 1986 ; 43: 1486-1488.
496	Ziar	Lor E, Sheybani T, Takagi J. Visual compatibility of fluconazole with commonly used injectable drugs during simulated Y-site administration. Am J Hosp Pharm 1991 ; 48: 744-746.
604	Laborator	Stabilité des médicaments dans l'Intermate® SV50, 100, 200 Baxter 1998
1135	Ziar	Baltz JK, Kennedy P, Minor JR, Gallelli J. Visual compatibility of foscarnet with other injectable drugs during simulated Y-site administration. Am J Hosp Pharm 1990 ; 47: 2075-2077.
1235	Ziar	Leigh PH, Buddle GC. Pentamidine infusion stability. Br J Pharm Pract 1988 ; 10: 22-23.
1625	Ziar	Trissel LA, Saenz C, Williams YW, Ingram D. Incompatibilities of lansoprazole injection with other drugs during simulated Y-site coadministration. Int J Pharm Compound 2001 ; 5: 314-321.
1925	Ziar	Trissel LA , Williams KY, Gilbert DL. Compatibility screening of linezolid injection during simulated Y-site administration with other drugs and infusion solutions. J Am Pharm Assoc 2000 ; 40: 515-519.
3543	Laborator	Ceftazidime – Summary of Product Characteristics Wockhardt 2013
3559	Laborator	Pentamidine diiséthionate (Pentacarinat®) - Résumé des caractéristiques du produit Sanofi Aventis France 2013
3560	Laborator	Linezolid (Zyvox®) - Summary of Product Characteristics Pharmacia 2013
3662	Laborator	Foscavir (Foscarnet®) - Summary of Product Characteristics Clinigen 2014

Mentions Légales